Navigation Links
Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
Date:11/22/2013

-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.

Sanofi Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended.  Forward-looking statements are statements that are not historical facts.  These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance.  Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans" and similar expressions.  Although Sanofi's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements.  These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clin
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur to add 2D barcode to six more vaccines
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
8. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
9. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... ORLANDO, Fla. , June 2, 2015  One ... Master of Science in Nurse Anesthesia (MSNA) graduates of ... on their first attempt. The graduating class was composed ... 20, 2015.  The NCE is required ... Registered Nurse Anesthetist, and graduates of the MSNA program ...
(Date:6/2/2015)... June 2, 2015 ANI Pharmaceuticals, Inc. ("ANI") ... received approval from the U.S. Food and Drug Administration ... Oxycodone Hydrochloride Oral Solution 5mg/5mL. Trailing twelve-month sales for ... three current competitors. ANI expects to begin shipping to ... , President and CEO of ANI Pharmaceuticals, stated, "This ...
(Date:6/2/2015)... San MediTech, the industry leader in ... for diabetics, announced its plan to attend the American ... Boston on June 5 th to ... Monitoring System (DGMS). The company plans to show industry ... technologies and advancements made by Chinese medical device companies. ...
Breaking Medicine Technology:ADU's Master of Science in Nurse Anesthesia April 2015 Graduates Earn 100 Percent First Time Pass Rate on National Certification Examination 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 4
... Dec. 17 A leading cancer physician and,researcher ... network specializing in Phase I - Phase IV ... trial conducted to,increase pathologic complete response (pCR) and ... subsequent pCR for patients with,stage 2 and 3 ...
... SuperGen, Inc.,(Nasdaq: SUPG ) today ... in a multi-arm Phase 1b clinical trial ... inhibitor (TKI). The trial will evaluate,MP470 in ... regimens,including carboplatin/paclitaxel, carboplatin/etoposide, docetaxel,topotecan, and erlotinib. The ...
Cached Medicine Technology:US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium 2US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium 3US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium 4SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor 2SuperGen Reports Initiation of Multi-arm Phase 1b Trial of Novel Tyrosine Kinase Inhibitor 3
(Date:6/2/2015)... ANT Wireless, proven innovator in ultra-low ... two new products implementing the ANT+ Fitness Equipment Control ... interoperability in their bike trainer products, built to create ... implemented the FE-C device profile in its Vortex Smart ... new indoor training software, while Kinomap has added FE-C ...
(Date:6/2/2015)... Acara Partners has seen a spike in demand for ... as is now required by recent Google search algorithm changes. ... several new clients in the medical aesthetics vertical, are anxious ... meet Google’s new requirements,” commented Fran Acunzo, CEO of Acara ... education, non-profits, and the business world.” , Back in ...
(Date:6/2/2015)... 2015 Though almost the entire Park family ... the disease rule their lives. Organizing and hosting the June ... living life to the fullest and spreading awareness of HHT. ... but I won't live my life in a bubble because ... you'd want is to look back on your life with ...
(Date:6/2/2015)... BC (PRWEB) June 02, 2015 ... report by iData Research ( http://www.idataresearch.com ), the ... and demineralized bone matrices (DBM) over traditional allograft ... two incisions and thus an increase in operation ... The strong market growth in these synthetic materials ...
(Date:6/2/2015)... Williamsport, PA (PRWEB) June 02, 2015 ... Survey indicate that while there has been a ... (e-cigarettes) has tripled and waterpipe vapor (hookah) usage has ... Health Pediatrician Dr. Russell Gombosi believes the national ... that it could take 15 to 20 years to ...
Breaking Medicine News(10 mins):Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Acara Partners Expands Website and Digital Offerings 2Health News:Family brings awareness to genetic disease at first Memphis walk 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 2Health News:Medtronic, DePuy Synthes Shift U.S. Bone Graft Substitute Market Towards Synthetic Demineralized Bone Matrices 3Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 2Health News:Susquehanna Health Pediatrician Warns of Adverse Effects of Teen E-Cigarette Usage 3
... More and ... Milk Their Diets, BIRMINGHAM, Ala., Aug. 22 The ... -- which seem to go in,and out of fashion like shoulder pads and ... 25 percent of,Alabama residents -- remain overweight or obese., A new campaign ...
... to Lead Effort to End Malaria Deaths, NEW ... to raise awareness and galvanize support to address the ... Case to the,post of Chief Executive Officer, effective immediately. ... of Malaria No More in December 2006,has served as ...
... 22 Corbett Accel Healthcare Group (CAHG),is proud ... Executive Vice,President, Interactive Marketing & eInnovation, Corbett Accel ... become a member of the Executive,Leadership Team of ... a,leading digital interactive communications agency. Melick is based ...
... -, FREMONT, Calif., Aug. 22 Vermillion, ... announced the publication,of data supporting its peripheral artery ... the August, 2008 issue of the peer-reviewed,journal, Vascular ... MD, PhD,Professor of Medicine at Stanford University and ...
... launch the most sophisticated mission ever to investigate the ... of our planet the geoid - with unprecedented ... Ocean Circulation Explorer (GOCE) will be placed onto a ... vehicle launched from the Plesetsk Cosmodrome in Northern Russia, ...
... of cancer-causing compounds , , FRIDAY, Aug. 22 (HealthDay News) ... too, without producing harmful cancer-causing compounds, new research shows. ... antioxidant-rich spice blends can reduce the risk of these ... , "If you are concerned about carcinogens, marinating a ...
Cached Medicine News:Health News:Message to Birmingham Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Birmingham Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Malaria No More Names Scott Case Chief Executive Officer 2Health News:Corbett Accel Healthcare Group Announces Promotion of Geoff Melick to Executive Vice President, Interactive Marketing & eInnovation 2Health News:Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 2Health News:Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 3Health News:GOCE Earth explorer satellite to look at the Earth's surface and core 2Health News:Marinades Help Keep Grilled Meat Safe 2Health News:Marinades Help Keep Grilled Meat Safe 3
Round handle dull finish. For right handed surgeon....
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm....
Irrigating nucleus chopper, tip angled 30 to side wedge shaped inferior edge with blunt tip and front notch for engaging iris end opening, 19 gauge. For use in the right hand....
Irrigating nucleus chopper, 0.6 mm dual sideports, 20 gauge. For the right handed surgeon....
Medicine Products: